Blood recycling device study in heart surgery
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial looks at how a device that collects and reuses your own blood during heart surgery works. It may help reduce the need for donated blood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are having standard heart surgery (not redo surgery, dissection, endocarditis, or a transplant)
- You will receive a device that recycles your own blood during surgery
- You can agree to take part in the study
- You do not have severe anemia (blood level below 7 g/dL)
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using your own donated platelets during heart surgery can help you recover better. Platelets are cells that help your blood clot, and donating them before surgery may reduce the need for donor blood.
This study watches how well platelets (cells that help blood clot) work in people who have high-risk heart surgery using a heart-lung machine for more than 2 hours. The goal is to learn more about bleeding risks after surgery.
This trial tests whether giving back a patient's own platelets and red blood cells during heart surgery can reduce bleeding and the need for donor blood transfusions. It is for people having certain types of high-risk heart surgery with a heart-lung machine.
This trial tests whether collecting and re-infusing your own blood during heart surgery reduces the need for donor blood transfusions. It's for adults having planned bypass surgery with a heart-lung machine.
This study tests whether giving blood transfusions based on each patient's needs during and after heart surgery is safe and effective. It compares different transfusion thresholds to see which works better.
This study tests a new way to manage blood during surgery, which may reduce the need for donor blood transfusions. It compares standard care with a method that uses your own blood and a special device to monitor your blood flow.
Hear when a new Platelets trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.